229 related articles for article (PubMed ID: 9584337)
1. Continuous infusion of chemotherapy: focus on 5-fluorouracil and fluorodeoxyuridine.
Poorter RL; Bakker PJ; Veenhof CH
Pharm World Sci; 1998 Apr; 20(2):45-59. PubMed ID: 9584337
[TBL] [Abstract][Full Text] [Related]
2. Continuous delivery of venous 5-fluorouracil and arterial 5-fluorodeoxyuridine for hepatic metastases from colorectal cancer: feasibility and tolerance in a randomized phase II trial comparing flat versus chronomodulated infusion.
Focan C; Levi F; Kreutz F; Focan-Henrard D; Lobelle JP; Adam R; Dallemagne B; Jehaes C; Markiewicz S; Weerts J; Bismuth H; Jasmin C; Misset JL
Anticancer Drugs; 1999 Apr; 10(4):385-92. PubMed ID: 10378673
[TBL] [Abstract][Full Text] [Related]
3. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma.
Lorenz M; Müller HH
J Clin Oncol; 2000 Jan; 18(2):243-54. PubMed ID: 10637236
[TBL] [Abstract][Full Text] [Related]
4. Role of fluoropyrimidine Schedule and (6R,S)leucovorin dose in a preclinical animal model of colorectal carcinoma.
Cao S; Frank C; Rustum YM
J Natl Cancer Inst; 1996 Apr; 88(7):430-6. PubMed ID: 8618234
[TBL] [Abstract][Full Text] [Related]
5. Phase II trial of circadian infusion floxuridine (FUDR) in hormone refractory metastatic prostate cancer.
Rajagopalan K; Peereboom D; Budd GT; Olencki T; Murthy S; Elson P; McLain D; Bukowski R
Invest New Drugs; 1998-1999; 16(3):255-8. PubMed ID: 10360605
[TBL] [Abstract][Full Text] [Related]
6. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
[TBL] [Abstract][Full Text] [Related]
7. Improved hepatic toxicity profile of portal vein adjuvant hepatic infusional chemotherapy.
Faynsod M; Wagman LD; Longmate J; Carroll M; Leong LA
J Clin Oncol; 2005 Aug; 23(22):4876-80. PubMed ID: 16009960
[TBL] [Abstract][Full Text] [Related]
8. Phase III study of bolus versus infusion fluorouracil with or without cisplatin in advanced colorectal cancer.
Hansen RM; Ryan L; Anderson T; Krzywda B; Quebbeman E; Benson A; Haller DG; Tormey DC
J Natl Cancer Inst; 1996 May; 88(10):668-74. PubMed ID: 8627643
[TBL] [Abstract][Full Text] [Related]
9. Continuous infusion 5-fluorouracil as first-line therapy for metastatic breast cancer.
Chu L; Sutton LM; Peterson BL; Havlin KA; Winer EP
J Infus Chemother; 1996; 6(4):211-6. PubMed ID: 9229318
[TBL] [Abstract][Full Text] [Related]
10. Technical complications of continuous intra-arterial chemotherapy with 5-fluorodeoxyuridine and 5-fluorouracil for colorectal liver metastases.
Heinrich S; Petrowsky H; Schwinnen I; Staib-Sebler E; Gog C; El-Ganainy A; Gutt C; Müller HH; Lorenz M
Surgery; 2003 Jan; 133(1):40-8. PubMed ID: 12563236
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of 5-fluorouracil following hepatic intra-arterial infusion in a VX2 hepatic metastasis model.
Sadahiro S; Suzuki T; Ishikawa K; Tanaka Y; Masuda T; Nakamura T; Yasuda S; Makuuchi H; Murayama C
Jpn J Clin Oncol; 2003 Aug; 33(8):377-81. PubMed ID: 14523056
[TBL] [Abstract][Full Text] [Related]
12. Is hepatic infusion of chemotherapy effective treatment for liver metastases? Yes!
Kemeny NE
Important Adv Oncol; 1992; ():207-27. PubMed ID: 1533847
[No Abstract] [Full Text] [Related]
13. [Recent advance in chemotherapy for advanced colorectal cancer].
Aiba K
Gan To Kagaku Ryoho; 1996 Apr; 23(5):535-48. PubMed ID: 8678510
[TBL] [Abstract][Full Text] [Related]
14. Chronomodulated 5-day infusion of floxuridine and L-folinic acid in patients with advanced malignancies: a feasibility and tolerability study.
Garufi C; Lévi F; Giunta S; Aschelter A; Pace R; Nisticò C; Terzoli E
J Infus Chemother; 1995; 5(3 Suppl 1):134-7. PubMed ID: 8528973
[TBL] [Abstract][Full Text] [Related]
15. Advanced colorectal cancer: quality of life and toxicity in patients after weekly 24-hour continuous infusions of biomodulated 5-fluorouracil.
Bogliolo G; Pannacciulli I; Desalvo L; Barsotti B; Lerza R; Mencoboni M; Arboscello E
Anticancer Res; 2000; 20(1B):501-4. PubMed ID: 10769713
[TBL] [Abstract][Full Text] [Related]
16. Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer.
; Piedbois P; Buyse M; Kemeny N; Rougier P; Carlson R; Allen-Mersh T; O'Connell M; Chang A; Sondak V; Kemeny M; Levy E
J Natl Cancer Inst; 1996 Mar; 88(5):252-8. PubMed ID: 8614003
[TBL] [Abstract][Full Text] [Related]
17. Is continuous 24-hour infusion of 5-fluorouracil plus high-dose folinic acid effective in patients with progressive or recurrent colorectal cancer? A phase II study.
Hartmann JT; Köhne CH; Schmoll HJ; Daikeler T; Kanz L; Bokemeyer C
Oncology; 1998; 55(4):320-5. PubMed ID: 9663421
[TBL] [Abstract][Full Text] [Related]
18. Alternating bolus and continuous infusion 5-fluorouracil: a strategy to overcome resistance to this fluoropyrimidine in advanced colorectal cancer patients.
Guglielmi A; Aschele C; Grossi F; Tixi L; Sobrero A
Cytotechnology; 1996; 19(3):215-9. PubMed ID: 8862009
[TBL] [Abstract][Full Text] [Related]
19. [Infusiontherapy with 5-fluorouracil ("infusional" 5-FU) in solid tumors].
Wilke H; Stahl M; Köster W; Vanhöfer U
Med Klin (Munich); 2000 Jun; 95 Suppl 1():3-8. PubMed ID: 10941246
[TBL] [Abstract][Full Text] [Related]
20. Hepatic arterial chemotherapy for colorectal cancer metastatic to the liver.
van Riel JM; van Groeningen CJ; Giaccone G; Pinedo HM
Oncology; 2000 Aug; 59(2):89-97. PubMed ID: 10971164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
